Summary
- Current Price
- As of today, CARM price is $0.00, down -23.08% on
- Current Price All-Time High
- CARM price is currently -100.00% below its historical high of $386.66 set on
- Market Cap
- CARM current market cap is $42K, down -99.53% year-over-year
- PE Ratio
- CARM current PE ratio is 0.01
- Revenue
- CARM current annual revenue is $19.63M, up +31.59% year-over-year
- Next Earnings
- As of today, the next earnings release for CARM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Carisma Therapeutics, Inc. |
| Ticker | NASDAQ: CARM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | carismatx.com |
| Employees | 46 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| Price, 1D Change | -23.08% | |
| $42K | ||
| - | ||
| 0.01 | ||
| 5.63 | ||
| $19.63M | ||
| Revenue, 1Y Change | +31.59% | |
| -$1.46 | ||
| EPS, 1Y Change | +43.71% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.36 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SESN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.46 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $19.63M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $0.00 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.59 | - | |
| - | -$1.46 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $14.92M | - | |
| - | $19.63M | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -99.53% | ||
| -99.98% | ||
| -99.53% | ||
| -99.98% | ||
| +31.59% | ||
| -26.04% | ||
| +43.71% | ||
| -3,864.13% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| $0.02 | ||
| $0.00 | ||
| $0.07 | ||
| $0.00 | ||
| -$0.00 | ||
| 5.63 | ||
| $0.00 | ||
| 50.00 | ||
| 616.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| $0.36 | ||
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $19.63M | ||
| -$1.46 | ||
| $16.28M | ||
| 82.92% | ||
| -$62.18M | ||
| -316.72% | ||
| -$60.48M | ||
| -308.05% | ||
| -$58.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -0.09 | ||
| 1.48 | ||
| 1.48 | ||
| - | ||
| 4 | ||
| -19.83 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 0.00 | ||
| -0.05 | ||
| -0.15 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$27.91M | ||
| $17.91M | ||
| $30.46M | ||
| $23.83M | ||
| $58.37M | ||
| $16.06M | ||
| $2.48M | ||
| $1.74M | ||
| $2.08M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $80.11M | ||
| $78.46M | ||
| $3.35M | ||
| $0.00 | ||
| $3.35M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$59.92M | ||
| -$123.00K | ||
| $344.00K | ||
| $123.00K | ||
| -$60.04M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| Baird | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CARM
FAQ
- What is the ticker symbol for Carisma Therapeutics, Inc.?
- The ticker symbol for Carisma Therapeutics, Inc. is NASDAQ:CARM
- Does Carisma Therapeutics, Inc. pay dividends?
- No, Carisma Therapeutics, Inc. does not pay dividends
- What sector is Carisma Therapeutics, Inc. in?
- Carisma Therapeutics, Inc. is in the Healthcare sector
- What industry is Carisma Therapeutics, Inc. in?
- Carisma Therapeutics, Inc. is in the Biotechnology industry
- What country is Carisma Therapeutics, Inc. based in?
- Carisma Therapeutics, Inc. is headquartered in United States
- When did Carisma Therapeutics, Inc. go public?
- Carisma Therapeutics, Inc. initial public offering (IPO) was on February 6, 2014
- Is Carisma Therapeutics, Inc. in the S&P 500?
- No, Carisma Therapeutics, Inc. is not included in the S&P 500 index
- Is Carisma Therapeutics, Inc. in the NASDAQ 100?
- No, Carisma Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Carisma Therapeutics, Inc. in the Dow Jones?
- No, Carisma Therapeutics, Inc. is not included in the Dow Jones index
- When was Carisma Therapeutics, Inc. last earnings report?
- Carisma Therapeutics, Inc.'s most recent earnings report was on August 7, 2025
- When does Carisma Therapeutics, Inc. report earnings?
- The date for Carisma Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CARM Official Website www.carismatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1485003/000162828025020724/0001628280-25-020724-index.htm
- CARM Profile on Yahoo Finance finance.yahoo.com/quote/CARM
- CARM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/carm